CPZ and encephalomyelitis: Likewise, the demonstration that CPZ ameliorates and/or prevents the clinical and pathological features of EAE and Theiler’s virus encephalomyelitis (Maña et al., 2009; Herder et al., 2012), is consistent with CPZ suppressing peripheral immune function and hence improving both clinical and pathological features driven by T-cells.